Table 1.
Baseline laboratory values by baseline PTH strata
| Mean (SD) | PTH <600 pg/ml |
PTH 600–1000 pg/ml |
PTH >1000 pg/ml |
|||
|---|---|---|---|---|---|---|
| Etelcalcetide (n = 172) | Placebo (n = 169) | Etelcalcetide (n = 225) | Placebo (n = 233) | Etelcalcetide (n = 112) | Placebo (n = 112) | |
| PTH, pg/ml | n = 172 | n = 169 | n = 225 | n = 233 | n = 112 | n = 112 |
| 509.8 (71.0) | 501.9 (66.6) | 780.6 (120.6) | 779.7 (129.2) | 1497.6 (679.1) | 1456.8 (666.8) | |
| Ca, mmol/l | n = 172 | n = 169 | n = 225 | n = 233 | n = 112 | n = 112 |
| 2.39 (0.16) | 2.39 (0.13) | 2.41 (0.17) | 2.42 (0.17) | 2.44 (0.16) | 2.44 (0.18) | |
| P, mmol/l | n = 168 | n = 168 | n = 223 | n = 232 | n = 110 | n = 107 |
| 1.78 (0.436) | 1.73 (0.462) | 1.92 (0.533) | 1.92 (0.472) | 2.01 (0.559) | 2.02 (0.526) | |
| Patients on vitamin D, % | 76 | 70 | 67 | 72 | 61 | 53 |
| Vitamin-D dose, μg/wk | n = 129 | n = 116 | n = 147 | n = 164 | n = 67 | n = 58 |
| 15.35 (13.00) | 15.65 (17.46) | 16.18 (13.63) | 15.23 (12.89) | 17.63 (15.35) | 14.84 (11.50) | |
Vitamin-D dose is presented as intravenous paricalcitol equivalents.
Ca, albumin-corrected serum calcium concentration; P, phosphate; PTH, parathyroid hormone.